In this episode, James Sapirstein, CEO of Cocrystal Pharma, shares insights into antiviral drug development, the company's innovative platform, and the future of infectious disease treatments. Discover how their unique approach aims to tackle viruses like norovirus, influenza, and rhinovirus, and what it takes to bring these solutions from lab to patient. Cocrystal Pharma Website: <a rel="noopener noreferrer nofollow" href="https://www.cocrystalpharma.com/" target="_blank">https://www.cocrystalpharma.com/</a>Nano Cap Podcast: <a rel="noopener noreferrer nofollow" href="https://www.nanocappod.com/" target="_blank">https://www.nanocappod.com/</a>DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

Rank One Computing - $ROC - Ep:076 - Nano Cap Podcast

On the Nano Cap Podcast, we dive into the unique world of publicly traded companies with a market capitalization under $50 million – the nano caps. These are not just numbers on a stock ticker; they are stories of ambition, struggle, and triumph.

Each episode, I'll sit down with the leaders and visionaries behind these companies. We’ll uncover the challenges they face, the innovations they bring, and the strategies that drive them forward in a competitive market.